Ozlem Yedier-Bayram

Genome-wide CRISPR screen identifies PRC2 and KMT2D-COMPASS as regulators of distinct EMT trajectories that contribute differentially to metastasis

Yun Zhang, Joana Liu Donaher, Sunny Das et al. · Nature Cell Biology · 2022 · 122 citations · Full text

Genetics, Cancer Cell Biology, Cancer Genomics +9

Serum leptin, prolactin and vascular endothelial growth factor (VEGF) levels in patients with breast cancer.

Uğur Çoşkun, Nazan Günel, Füsun Baloş Törüner et al. · PubMed · 2003 · 58 citations

Tumor Biology, Breast Oncology, Angiogenesis +13

Exploiting epigenetic targets to overcome taxane resistance in prostate cancer

Buse Cevatemre, İpek Bulut, Beyza Dedeoğlu et al. · Cell Death and Disease · 2024 · 18 citations · Full text

Role of endogenous endothelin peptides in intestinal ischemia-reperfusion injury in rats

Ahmet Ziya Anadol, Ozlem Yedier-Bayram, Ayşe Dursun et al. · Prostaglandins Leukotrienes and Essential Fatty Acids · 1998 · 17 citations

Inflammation, Medicine, Physiology +7

EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilities

Ozlem Yedier-Bayram, Bengul Gokbayrak, Alişan Kayabölen et al. · Cell Death and Disease · 2022 · 17 citations · Full text